Vanguard Capital Management’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$864K Buy
+43,331
New +$867K ﹤0.01% 3598

Other funds holding ADRX

Vanguard Capital Management's ADRX Position: Q3 2026 in Review

Vanguard Capital Management opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 43,331 shares worth $864K. The stake represents ﹤0.01% of the portfolio and ranks #3598 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Vanguard Capital Management held 43,331 shares of ADARx Pharmaceuticals worth $864K as of Q3 2026.
  • ADARx Pharmaceuticals was a new Vanguard Capital Management position in Q3 2026.
  • ADARx Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3598 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.